KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Invested Capital (2016 - 2026)

Boston Scientific's Invested Capital history spans 18 years, with the latest figure at $26.5 billion for Q1 2026.

  • On a quarterly basis, Invested Capital fell 21.63% to $26.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $26.5 billion, a 21.63% decrease, with the full-year FY2025 number at $24.7 billion, up 13.38% from a year prior.
  • Invested Capital hit $26.5 billion in Q1 2026 for Boston Scientific, up from $24.7 billion in the prior quarter.
  • Over the last five years, Invested Capital for BSX hit a ceiling of $35.2 billion in Q3 2025 and a floor of -$60.0 million in Q2 2025.
  • Historically, Invested Capital has averaged $19.3 billion across 5 years, with a median of $23.3 billion in 2022.
  • Biggest five-year swings in Invested Capital: skyrocketed 1033.94% in 2023 and later tumbled 100.56% in 2025.
  • Tracing BSX's Invested Capital over 5 years: stood at $2.5 billion in 2022, then skyrocketed by 1033.94% to $28.6 billion in 2023, then fell by 23.97% to $21.8 billion in 2024, then grew by 13.38% to $24.7 billion in 2025, then grew by 7.17% to $26.5 billion in 2026.
  • Business Quant data shows Invested Capital for BSX at $26.5 billion in Q1 2026, $24.7 billion in Q4 2025, and $35.2 billion in Q3 2025.